Mizuho upgraded shares of Santen Pharmaceutical (OTCMKTS:SNPHY) from a neutral rating to a buy rating in a report published on Monday, The Fly reports.
SNPHY opened at $13.89 on Monday. The firm has a fifty day moving average price of $13.31. Santen Pharmaceutical has a 1 year low of $12.50 and a 1 year high of $20.93.
About Santen Pharmaceutical
Recommended Story: Market Timing – The Benefits and the Danger
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.